Literature DB >> 16153900

Investigating the role of the growth hormone-insulin-like growth factor (GH-IGF) axis as a determinant of male bone mineral density (BMD).

M B R Patel1, N K Arden, L M Masterson, D I W Phillips, R Swaminathan, H E Syddall, C D Byrne, P J Wood, C Cooper, R I G Holt.   

Abstract

INTRODUCTION: The GH-IGF axis has profound effects on bone metabolism and may be important in the etiology of idiopathic osteoporosis. Serum IGF-I is often low in men with osteoporosis, which may be attributable to GH hypo-secretion or hepatic GH insensitivity. We studied the GH-IGF axis in depth to look for evidence to support these hypotheses.
MATERIALS AND METHODS: 28 healthy 60- to 70-year-old men with low, intermediate, or normal BMD were studied. GH secretion was measured by overnight urine collection. GH reserve was assessed by exercise and glucagon stimulation tests. Hepatic IGF-I production was investigated using a GH-IGF-I generation test. Data were analyzed using Pearson's correlation coefficient, linear regression, and analysis of variance.
RESULTS: Serum IGF-I was reduced in subjects with low BMD (P = 0.009). There was no difference in GH secretion or reserve between the groups. Overall, GH reserve and IGF-I were positively related but this was attenuated in the low BMD group. However, no statistically significant difference in IGF-I generation capacity between BMD groups was found.
CONCLUSIONS: Men with reduced BMD have low IGF-I but normal GH secretion and reserve. Our data suggested, but could not confirm, hepatic resistance to GH as a mechanism for this association.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153900     DOI: 10.1016/j.bone.2005.06.016

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  14 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass.

Authors:  Pamela S Hinton; Peggy Nigh; John Thyfault
Journal:  Bone       Date:  2016-10-12       Impact factor: 4.398

3.  Low levels of plasma IGF-1 inhibit intracortical bone remodeling during aging.

Authors:  Hayden-William Courtland; Oran D Kennedy; Yingjie Wu; Ying Gao; Hui Sun; Mitchell B Schaffler; Shoshana Yakar
Journal:  Age (Dordr)       Date:  2012-09-14

4.  Gender aspects of osteoporosis and bone strength.

Authors:  Janina M Patsch; Julia Deutschmann; Peter Pietschmann
Journal:  Wien Med Wochenschr       Date:  2011-03

5.  Milk, rather than other foods, is associated with vertebral bone mass and circulating IGF-1 in female adolescents.

Authors:  L Esterle; J-P Sabatier; F Guillon-Metz; O Walrant-Debray; G Guaydier-Souquières; F Jehan; M Garabédian
Journal:  Osteoporos Int       Date:  2008-08-14       Impact factor: 4.507

6.  Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-term GH treatment on bone in adults with a mutation in the GHRH-receptor gene.

Authors:  Francisco J A de Paula; Miburge B Góis-Júnior; Manuel H Aguiar-Oliveira; Francisco de A Pereira; Carla R P Oliveira; Rossana M C Pereira; Catarine T Farias; Tábita A R Vicente; Roberto Salvatori
Journal:  Clin Endocrinol (Oxf)       Date:  2008-05-20       Impact factor: 3.478

Review 7.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 8.  Function of matrix IGF-1 in coupling bone resorption and formation.

Authors:  Janet L Crane; Xu Cao
Journal:  J Mol Med (Berl)       Date:  2013-09-26       Impact factor: 4.599

Review 9.  Growth hormone, IGF-I and insulin and their abuse in sport.

Authors:  R I G Holt; P H Sönksen
Journal:  Br J Pharmacol       Date:  2008-03-31       Impact factor: 8.739

10.  The influence of serum ghrelin, IGF axis and testosterone on bone mineral density in boys at different stages of sexual maturity.

Authors:  Triin Pomerants; Vallo Tillmann; Jaak Jürimäe; Toivo Jürimäe
Journal:  J Bone Miner Metab       Date:  2007-04-20       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.